TREATMENT OF RELAPSED WILMS TUMOUR (WT) PATIENTS: EXPERIENCE WITH TOPOTECAN

被引：0

作者：

Mavinkurve-Groothuis, A. M. C. ^{[1
]}

van den Heuvel-Eibrink, M. M. ^{[2
]}

Tytgat, G. A. ^{[3
]}

van Tinteren, H. ^{[4
]}

Vujanic, G. ^{[5
]}

Pritchard-Jones, K. ^{[6
]}

Howell, L. ^{[7
]}

Graf, N. ^{[8
]}

Bergeron, C. ^{[9
]}

Acha, T. ^{[10
]}

Spreafico, F. ^{[11
]}

机构：

[1] Radboudumc, Dept Pediat Hematol & Oncol, Nijmegen, Netherlands

[2] ErasmusMC Sophia Childrens Hosp, Dept Pediat Hematol & Oncol, Rotterdam, Netherlands

[3] Emma Childrens Hosp, Dept Pediat Oncol, Amsterdam, Netherlands

[4] Dutch Canc Inst NKI AvL, Dept Stat, Amsterdam, Netherlands

[5] Cardiff Univ, Sch Med, Dept Pathol, Cardiff CF10 3AX, S Glam, Wales

[6] UCL, Inst Child Hlth, London, England

[7] Alder Hey Childrens NHS Fdn Trust, Dept Pediat Oncol, Liverpool, Merseyside, England

[8] Univ Saarland, Homburg, Germany

[9] Inst Hematol & Oncol Pediat, Lyon, France

[10] Hosp Maternoinfantil, Dept Pediat Oncol, Malaga, Spain

[11] Fdn IRCCS Ist Nazl Tumori, Dept Hematol & Pediat Oncol, Pediat Oncol Unit, Milaan, Italy

来源：

PEDIATRIC BLOOD & CANCER | 2014年 / 61卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-262

引用

页码：S229 / S229

页数：1

共 50 条

[31] Incidence and outcomes of patients with late recurrence of Wilms tumor (WT): The international experience.
Malogolowkin, M. H.
Spreafico, F.
Dome, J.
Breslow, N.
van Tinteren, H.
Pritchard-Jones, K.
van den Heuvel, M.
Bergeron, C.
De Kraker, J.
Graf, N.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[32] The Wilms tumour gene, WT1, in normal and abnormal nephrogenesis
Pritchard-Jones, K
PEDIATRIC NEPHROLOGY, 1999, 13 (07) : 620 - 625
[33] Wilms' tumour gene 1 (WT1) in human neoplasia
Keilholz, U
Menssen, HD
Gaiger, A
Menke, A
Oji, Y
Oka, Y
Scheibenbogen, C
Stauss, H
Thiel, E
Sugiyama, H
LEUKEMIA, 2005, 19 (08) : 1318 - 1323
[34] The Wilms tumour gene, WT1, in normal and abnormal nephrogenesis
Pritchard-Jones K.
Pediatric Nephrology, 1999, 13 (7) : 620 - 625
[35] Transcriptional regulation by the Wilms' tumour suppressor protein WT1
Wagner, KJ
Roberts, SGE
BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 : 932 - 935
[36] Identification of a new WT1 mutation in a sporadic Wilms' tumour
Santos, AC
Boavida, MG
Costa, A
Osorio-Almeida, L
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1998, 1407 (02): : 109 - 113
[37] Wilms' tumour and the WT1 tumour supressor gene: Disease, development, evolution and multifunctionality
Hastie, N
JOURNAL OF MEDICAL GENETICS, 2001, 38 : S30 - S30
[38] Transatlantic controversies in the treatment of Wilms' tumour
Stevens, M. C. G.
EUROPEAN JOURNAL OF CANCER, 2007, 43 (17) : 2450 - 2452
[39] Wilms' tumour - Optimal treatment strategies
Suryanarayan, K
Marina, N
DRUGS, 1998, 56 (04) : 597 - 605
[40] TREATMENT OF ADENOSARCOMA RENIS (WILMS TUMOUR)
BERGLUND, S
NORDISK MEDICIN, 1945, 25 (06) : 276 - 278

← 1 2 3 4 5 →